Literature DB >> 22197308

Using a discrete choice experiment to estimate health state utility values.

Nick Bansback1, John Brazier, Aki Tsuchiya, Aslam Anis.   

Abstract

In this study we explored a novel application of the discrete choice experiment (DCE) that resembles the time trade off (TTO) task to estimate values on the health utility scale for the EQ-5D. The DCE was tested in a survey alongside the TTO in a sample of English-speaking Canadians recruited by a market research company. The study found that the DCE is able to derive logical and consistent values for health states valued on the full health - dead scale. The DCE overcame some issues identified in the version of TTO currently used to value EQ-5D, notably allowing for fewer data exclusions and incorporating values considered worse than dead without introducing a separate valuation procedure. This has important implications for providing robust values that represent the preferences of all respondents.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 22197308     DOI: 10.1016/j.jhealeco.2011.11.004

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  68 in total

1.  Does Device or Connection Type Affect Health Preferences in Online Surveys?

Authors:  John D Hartman; Benjamin M Craig
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

2.  EQ-5D-5L Valuation for the Malaysian Population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo; Kim Rand-Hendriksen; Faridah Aryani Md Yusof
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

3.  Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?

Authors:  Brendan Mulhern; Richard Norman; Paula Lorgelly; Emily Lancsar; Julie Ratcliffe; John Brazier; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

4.  Valuing EQ-5D-5L health states 'in context' using a discrete choice experiment.

Authors:  Amanda Cole; Koonal Shah; Brendan Mulhern; Yan Feng; Nancy Devlin
Journal:  Eur J Health Econ       Date:  2017-05-31

5.  The better than dead method: feasibility and interpretation of a valuation study.

Authors:  R A van Hoorn; A R T Donders; M Oppe; P F M Stalmeier
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

6.  Values for health states with different life durations.

Authors:  Luciana Scalone; Peep F M Stalmeier; Silvano Milani; Paul F M Krabbe
Journal:  Eur J Health Econ       Date:  2014-09-30

Review 7.  Reconceptualising the external validity of discrete choice experiments.

Authors:  Emily Lancsar; Joffre Swait
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

8.  The impact of a belief in life after death on health-state preferences: True difference or artifact?

Authors:  Michał Jakubczyk; Dominik Golicki; Maciej Niewada
Journal:  Qual Life Res       Date:  2016-07-21       Impact factor: 4.147

9.  Utility Values for the CP-6D, a Cerebral Palsy-Specific Multi-Attribute Utility Instrument, Using a Discrete Choice Experiment.

Authors:  Mina Bahrampour; Richard Norman; Joshua Byrnes; Martin Downes; Paul A Scuffham
Journal:  Patient       Date:  2020-10-19       Impact factor: 3.883

10.  US valuation of health outcomes measured using the PROMIS-29.

Authors:  Benjamin M Craig; Bryce B Reeve; Paul M Brown; David Cella; Ron D Hays; Joseph Lipscomb; A Simon Pickard; Dennis A Revicki
Journal:  Value Health       Date:  2014-12       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.